Prostate cancer. Gleason 4+3, PSA = 17.6.

April 13, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Your Prostate Cancer Results

Thank you for sharing this information. Let me help you understand what these findings mean so you can have more informed conversations with your care team.

What Your Results Tell Us

Gleason Score 4+3: Your Gleason score describes how the cancer cells look under a microscope compared to normal prostate cells. The score ranges from 2-10, where higher numbers mean the cancer cells look more abnormal.

  • Your score of 4+3 means the most common pattern is Grade 4 (moderately abnormal) and the second most common is Grade 3 (slightly abnormal)
  • This is considered intermediate to higher-risk disease based on NCCN Guidelines
  • The Gleason score helps predict how quickly the cancer might grow

PSA Level of 17.6 ng/mL: PSA (prostate-specific antigen) is a protein made by the prostate. According to NCCN Guidelines, PSA levels help assess your cancer risk:

  • A PSA of 17.6 is elevated (normal is typically under 4.0 ng/mL)
  • Combined with your Gleason score, this suggests intermediate-to-higher risk disease
  • PSA helps your doctors understand the extent of cancer and plan treatment

What Doctors Consider Next

According to NCCN Guidelines for Early-Stage Prostate Cancer, your care team will likely evaluate:

  1. Tumor stage (TNM staging) - Whether cancer is confined to the prostate or has spread to lymph nodes or distant areas
  2. Biopsy results - How many core samples contained cancer and where it's located in the prostate
  3. Your overall risk group - Combining PSA, Gleason score, tumor stage, and biopsy findings to determine treatment options

Treatment Approaches That Typically Apply

For patients with intermediate-to-higher risk prostate cancer like yours, NCCN Guidelines generally describe several options:

  • Active surveillance - Frequent monitoring with PSA tests and imaging if you choose to delay treatment
  • Radiation therapy - Often combined with hormone therapy (androgen deprivation therapy/ADT)
  • Surgery - Radical prostatectomy (removal of the prostate and surrounding tissue)
  • Hormone therapy - May be used alone or combined with other treatments to block testosterone that fuels cancer growth

Important Questions to Ask Your Oncologist

Since your specific situation requires your doctor's complete evaluation, here are key questions to discuss:

  1. What is my complete TNM stage, and what does that mean for my prognosis?
  2. What is my risk group classification, and how does that affect treatment options?
  3. Do you recommend surgery, radiation, active surveillance, or another approach—and why?
  4. If hormone therapy is recommended, how long would I take it, and what side effects should I expect?
  5. Are there any clinical trials appropriate for my specific situation?
  6. What imaging or additional testing do you recommend before we finalize a treatment plan?

Next Steps

Your oncologist will determine the most appropriate approach for YOUR case based on:

  • Complete staging information
  • Your age and overall health
  • Your preferences and life expectancy
  • The complete clinical picture

According to NCCN Guidelines, it's important to bring someone with you to appointments to listen, ask questions, and take notes. Don't hesitate to ask for clarification on anything you don't understand.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: